AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 301 min read$CHE

MCNAMARA KEVIN J sold $1.0M of CHE

MCNAMARA KEVIN J (president and CEO) sold 2,000 shares of CHEMED CORP (CHE) at $513.45 ($1.03M total) on 2026-09-28.

Original reporting
SEC EDGAR · MCNAMARA KEVIN J
Published Sep 30, 2026, 6:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 6:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CHE
Bearish
medium confidence
Mentioned
$CHE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHEBearishLow
01

Why it matters

The disclosed sale provides fresh information on insider sentiment, which can influence short‑term trading decisions.

02

Market read

A fresh insider sale by the CEO is a material event for CHE, offering a low‑actionability trading signal.

03

What to watch

No disclosed 10b5‑1 plan and the CEO retains a sizable stake, which may mitigate concerns.

Relevance 6/10Novelty 5/10Timing: filed Sep 30, 2026 (same‑day filing)

Background

Form 4 filings disclose insider transactions and are primary sources for new corporate actions.

Company-level read

Ticker impact

$CHEBearishMedium confidence
Context

CEO Kevin J. McNamara sold 2,000 shares of Chemed Corp for $1.03 M, reducing his stake to 66,418 shares.

Expected impact

likely slight downward pressure as investors price in the insider sale

Evidence & confidence

A $1 M sale by the CEO is material for a mid‑cap company and is a fresh Form 4 filing, prompting short‑term caution.

Market effects

Sector

Minimal; the sale does not affect the broader healthcare services sector.

Regional

Limited to U.S. investors tracking Chemed Corp.

Global

None

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to fundamentals, so the stock may remain stable.

Key entities

  • company
    Chemed Corp

    U.S. healthcare services provider (ticker CHE).

  • person
    Kevin J. McNamara

    President and CEO of Chemed Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CHE insider trading history →

Related articles

JUL 28
$CHEMed

Chemed Reports Second-Quarter 2026 Results

CHEMED CORP (CHE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 che-20260728xex99.htm EX-99 Exhibit 99 CONTACT: Michael D. Witzeman (513) 762- 6714  Chemed Reports Second-Quarter 2026 Results  Full-Year Guidance Increased Due Mainly to VITAS Outperformance   CINCINNATI, July 28, 2026— Chemed Corporation (Chemed) (NYSE: CHE ), whic

SEC EDGAR 8-K6 min
JUN 8
$CHEMed

Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas

Chemed Corp. (NYSE: CHE) said its wholly owned Roto-Rooter unit acquired an independent Roto-Rooter franchise covering 21 south Texas counties, including Corpus Christi, McAllen, Laredo and Brownsville, for about $12.0 million. The company operates Roto-Rooter plumbing and drain cleaning services and VITAS hospice care. The release includes standard forward-looking statement cautions.

manilatimes.net2 min